EyePoint Pharmaceuticals Inc. buy Capital One Financial Co.
Start price
11.12.23
/
50%
€18.40
Target price
11.12.24
€40.94
Performance (%)
-48.49%
Price
12.07.24
€9.48
Summary
This prediction is currently active. The BUY prediction by Capital_One_Financia for EyePoint Pharmaceuticals Inc. is performing very badly with a performance of -48.49%. This prediction currently runs until 11.12.24. The prediction end date can be changed by Capital_One_Financia at any time. Capital_One_Financia has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | - | - |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Capital_One_Financia for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $44.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat